Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M
As previously communicated the remediation program has continued at the Getinge production sites under the Consent Decree with FDA. A replanning of the ongoing remediation program has been conducted in Hechingen, Germany, and the Group has decided to make an additional provision of SEK 488 M to make the necessary changes. The costs are primarily attributable to increased staffing and process validation. After the decided provision the Group has a total remaining provision of SEK 710 M. As previously announced a US federal judge approved the terms of a Consent Decree between Getinge’s
